Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

In the video posted on X, Kennedy claimed mRNA vaccines were ineffective against mutated versions of the virus and revealed HHS is planning to reallocate the funding to research whole-virus vaccines, ...

The decision will impact 22 projects speerheaded by major pharmaceutical companies for vaccines against bird flu and other ...

The U.S. Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being ...

Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA vaccine research.

Shares of the biotech were up 4.3% in premarket trading, after it also beat Wall Street expectations for second-quarter ...

BioNTech’s second-quarter earnings came in at a loss of 1.60 euros a share on revenue of €261 million ($302.1 million), ...

President Donald Trump’s vaccine-bashing secretary of health and human services is canceling $500 million worth of vaccine ...

The US vaccines market, valued at $29.5B in 2024, is projected to reach $60B by 2033, at a CAGR of 8.2%. Key growth drivers include rising infectious diseases and biotech advancements. Comprehensive ...

WASHINGTON -- So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using ...

The U.S. Department of Health and Human Services said on Tuesday it would wind down mRNA vaccine development activities under ...

HHS canceled federal funding for mRNA vaccine development. Experts said this could affect our preparedness for future pandemics and innovations like cancer vaccines.